R S Schottenfeld

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States Electronic address
    Drug Alcohol Depend 136:36-42. 2014
  2. ncbi request reprint Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, 34 Park St S205, New Haven, CT 06519, USA
    Drug Alcohol Depend 118:48-55. 2011
  3. ncbi request reprint Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, Rm S204, New Haven, CT 06519, USA
    Am J Psychiatry 162:340-9. 2005
  4. ncbi request reprint Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities
    R S Schottenfeld
    CMHC SAC, Room S 205, 34 Park Street, New Haven, CT 06519, USA
    J Subst Abuse Treat 18:255-61. 2000
  5. ncbi request reprint Primary care-based ambulatory opioid detoxification: the results of a clinical trial
    M E Waugh
    Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8025, USA
    J Gen Intern Med 10:255-60. 1995
  6. pmc Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial
    M C Chawarski
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06519, USA
    Drug Alcohol Depend 115:237-9. 2011
  7. pmc Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients
    Declan T Barry
    Yale University School of Medicine, CMHC SAC Room 220, 34 Park St, New Haven, CT 06519 1187, USA declan barry yale edu
    J Clin Psychiatry 70:1213-8. 2009
  8. pmc Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients
    Emlyn S Jones
    Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine, 333 Cedar St, P O Box 208025, New Haven, CT, United States
    Drug Alcohol Depend 99:132-40. 2009
  9. ncbi request reprint Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Lancet 371:2192-200. 2008
  10. ncbi request reprint When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments
    S K Avants
    Substance Abuse Center, Yale University School of Medicine, New Haven, Connecticut 06529, USA
    J Consult Clin Psychol 66:924-31. 1998

Research Grants

Detail Information

Publications38

  1. doi request reprint Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States Electronic address
    Drug Alcohol Depend 136:36-42. 2014
    ....
  2. ncbi request reprint Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, 34 Park St S205, New Haven, CT 06519, USA
    Drug Alcohol Depend 118:48-55. 2011
    ..This study evaluated the efficacy of contingency management (CM), the community reinforcement approach (CRA), and twelve-step facilitation (TSF) for cocaine-dependent pregnant women or women with young children...
  3. ncbi request reprint Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, Rm S204, New Haven, CT 06519, USA
    Am J Psychiatry 162:340-9. 2005
    ..This study compares effects of buprenorphine and methadone and evaluates the efficacy of combining contingency management with maintenance treatment for patients with co-occurring cocaine and opioid dependence...
  4. ncbi request reprint Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities
    R S Schottenfeld
    CMHC SAC, Room S 205, 34 Park Street, New Haven, CT 06519, USA
    J Subst Abuse Treat 18:255-61. 2000
    ..g., planned pleasurable events or parenting activities) was associated with abstinence suggests that the planning and reinforcement of specific nondrug-related social, vocational, and recreational activities is a crucial component of CRA...
  5. ncbi request reprint Primary care-based ambulatory opioid detoxification: the results of a clinical trial
    M E Waugh
    Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8025, USA
    J Gen Intern Med 10:255-60. 1995
    ..Ambulatory opioid detoxification can give internists a larger role in initiating drug treatment for IDUs who are addicted to opioids...
  6. pmc Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial
    M C Chawarski
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06519, USA
    Drug Alcohol Depend 115:237-9. 2011
    ..Manual-guided behavioral drug and HIV risk reduction counseling is feasible to deliver by the trained MMT nursing personnel and appears to be a promising approach for improving the efficacy of standard MMT services in China...
  7. pmc Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients
    Declan T Barry
    Yale University School of Medicine, CMHC SAC Room 220, 34 Park St, New Haven, CT 06519 1187, USA declan barry yale edu
    J Clin Psychiatry 70:1213-8. 2009
    ..Differences in psychiatric distress and substance use (licit and illicit) were examined in methadone maintenance treatment (MMT) patients with a variety of pain experiences...
  8. pmc Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients
    Emlyn S Jones
    Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine, 333 Cedar St, P O Box 208025, New Haven, CT, United States
    Drug Alcohol Depend 99:132-40. 2009
    ..We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive...
  9. ncbi request reprint Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Lancet 371:2192-200. 2008
    ....
  10. ncbi request reprint When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments
    S K Avants
    Substance Abuse Center, Yale University School of Medicine, New Haven, Connecticut 06529, USA
    J Consult Clin Psychol 66:924-31. 1998
    ....
  11. doi request reprint Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial
    M C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA
    Drug Alcohol Depend 94:281-4. 2008
    ....
  12. ncbi request reprint Ambulatory opiate detoxification and primary care: a role for the primary care physician
    M E Waugh
    Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510
    J Gen Intern Med 7:532-4. 1992
    ..0001). Of 45 patients who ultimately completed AOD, 78% (35/45) remained in treatment for at least one month...
  13. ncbi request reprint Heroin dependence and HIV infection in Malaysia
    Marek C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA
    Drug Alcohol Depend 82:S39-42. 2006
    ..This, study evaluated drug use and other HIV risk behaviors and their association with HIV and other infectious diseases in heroin-dependent subjects enrolled in a clinical trial of drug abuse treatment in Muar, Malaysia...
  14. pmc Integrating buprenorphine treatment into office-based practice: a qualitative study
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 24:218-25. 2009
    ..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...
  15. pmc Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment
    Declan T Barry
    Yale University School of Medicine, New Haven, Connecticut 06519 1187, USA
    Am J Addict 18:117-21. 2009
    ..These findings may have implications for resource and program planning in MMT programs...
  16. ncbi request reprint Treatment of heroin dependence with buprenorphine in primary care
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Am J Drug Alcohol Abuse 28:231-41. 2002
    ..Eleven patients (79%) were retained through the maintenance phase. We conclude that buprenorphine maintenance is feasible in a primary care setting...
  17. pmc Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients
    Declan T Barry
    Yale University School of Medicine, CMHC SAC Room 220, 34 Park Street, New Haven CT 06519 1187, USA
    Am J Addict 18:379-85. 2009
    ..These findings may have implications for resource and program planning in MMTPs...
  18. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
    ..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
  19. pmc Opioids, chronic pain, and addiction in primary care
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Pain 11:1442-50. 2010
    ..Addressing these barriers to pain treatment will be crucial to improving pain management service delivery...
  20. pmc Exploring relations among traumatic, posttraumatic, and physical pain experiences in methadone-maintained patients
    Declan T Barry
    Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA
    J Pain 12:22-8. 2011
    ..Pain-related differences in trauma and screened symptoms of PTSD exist in MMT patients and may have implications for program planning and outreach efforts...
  21. pmc Conventional and unconventional treatments for stress among methadone-maintained patients: treatment willingness and perceived efficacy
    Declan T Barry
    Yale University School of Medicine, New Haven, CT 06519, USA
    Am J Addict 20:137-42. 2011
    ..These findings are likely to have implications for resource and program planning in MMT programs. ..
  22. pmc Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone
    David A Fiellin
    Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S33-8. 2011
    ..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
  23. pmc The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S54-61. 2011
    ..Cocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known...
  24. ncbi request reprint Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:S67-78. 2004
    ..Chart audits and mentoring should be considered as a mechanism to foster quality care. These processes of care are likely to require attention for treatment using methadone or buprenorphine...
  25. ncbi request reprint Linking process and outcome in the community reinforcement approach for treating cocaine dependence: a preliminary report
    Michael V Pantalon
    Department of Psychiatry, Yale University School of Medicine, APT Foundation, Inc, New Haven, Connecticut, USA
    Am J Drug Alcohol Abuse 30:353-67. 2004
    ..The findings of this preliminary study suggest the importance of monitoring both mechanistic and interpersonal processes during CRA treatment of cocaine dependence...
  26. ncbi request reprint Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
    N Engl J Med 355:365-74. 2006
    ..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
  27. ncbi request reprint A trial of integrated buprenorphine/naloxone and HIV clinical care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S184-90. 2006
    ..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
  28. pmc Patient satisfaction with primary care office-based buprenorphine/naloxone treatment
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 22:242-5. 2007
    ..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
  29. pmc Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients
    Brent A Moore
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    J Gen Intern Med 22:527-30. 2007
    ..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
  30. ncbi request reprint The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P O Box 208025, New Haven, CT 06520 8025, USA
    Drug Alcohol Depend 79:113-6. 2005
    ..Treatment outcomes with buprenorphine in a PCC do not vary based on history of prior methadone treatment...
  31. doi request reprint Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Am J Addict 17:116-20. 2008
    ..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
  32. doi request reprint Research- and community-based clinicians' attitudes on treatment manuals
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Am J Addict 17:145-8. 2008
    ..Findings suggest that community SUD clinicians are already familiar with and have positive attitudes toward manuals, but specific subgroups have concerns that should be addressed...
  33. pmc Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 35:87-92. 2008
    ..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
  34. pmc Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence
    Marek C Chawarski
    Yale University School of Medicine, New Haven, CT 06519, USA
    J Subst Abuse Treat 33:411-5. 2007
    ..3% were brought back attached to the skin) and that weekly sweat testing is less sensitive than weekly urine testing in detecting opiate use, suggest limited utility of sweat patch testing in outpatient clinical settings...
  35. ncbi request reprint Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms
    Marek C Chawarski
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 29:307-12. 2005
    ..Measures of withdrawal symptoms or illicit opioid use were not associated with buprenorphine dose, formulation, or plasma buprenorphine levels...
  36. ncbi request reprint A database model for studies of cocaine-dependent pregnant women and their families
    P A Charpentier
    Yale University School of Public Health, New Haven, CT 06520 8034, USA
    NIDA Res Monogr 166:242-53. 1996
    ..Although the database management systems are complex, they are based on standard database practices, used in widely available software packages, and run on inexpensive desktop computing equipment...
  37. ncbi request reprint Methadone maintenance in primary care: a randomized controlled trial
    D A Fiellin
    Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520 8025, USA
    JAMA 286:1724-31. 2001
    ..Office-based care of stabilized methadone maintenance patients is a promising alternative but no data are available from controlled trials regarding this type of program...
  38. ncbi request reprint New challenges and opportunities in managing substance abuse in Malaysia
    Mahmud Mazlan
    Substance Abuse Center, Muar, Malaysia
    Drug Alcohol Rev 25:473-8. 2006
    ..Despite these recent advances, treatments for amphetamine-type stimulant abuse or dependence are underdeveloped, and diversion of agonist medications is an emerging concern...

Research Grants36

  1. HIV Risk Reduction and Drug Abuse Treatment in Malaysia
    Richard Schottenfeld; Fiscal Year: 2002
    ..The results of the study will inform government policy and support for HIV prevention and drug abuse treatment efforts in Malaysia and possibly also in other Western Pacific countries. ..
  2. COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
    Richard Schottenfeld; Fiscal Year: 2000
    ..Utilization and costs of services, spillover effects in the PCC, and patient and staff perceptions of benefits and problems with PCC agonist maintenance treatment will also be evaluated. ..
  3. COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE
    Richard Schottenfeld; Fiscal Year: 2000
    ..abstract_text> ..
  4. Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
    Richard Schottenfeld; Fiscal Year: 2007
    ..Data analyses will focus on the intention-to treat sample. The study results will inform practice guidelines and policies regarding buprenorphine treatment. ..
  5. BRIEF BEHAVIORAL THERAPY TO ENHANCE TREATMENT ENGAGEMENT
    Richard Schottenfeld; Fiscal Year: 2001
    ..In Phase 4, we plan to develop gender and ethnicity specific videotapes and to pilot BEST in group therapy. ..
  6. Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
    Richard Schottenfeld; Fiscal Year: 2007
    ..Data analyses will focus on the intention-to treat sample. The study results will inform practice guidelines and policies regarding buprenorphine treatment. ..
  7. DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT
    Richard Schottenfeld; Fiscal Year: 2002
    ..The effects of baseline predictors and their interactions with treatment condition on these outcomes will also be evaluated. ..
  8. HIV Risk Reduction and Drug Abuse Treatment in Malaysia
    Richard Schottenfeld; Fiscal Year: 2002
    ..The results of the study will inform government policy and support for HIV prevention and drug abuse treatment efforts in Malaysia and possibly also in other Western Pacific countries. ..
  9. HIV Risk Reduction and Drug Abuse Treatment in Malaysia
    Richard Schottenfeld; Fiscal Year: 2003
    ..The results of the study will inform government policy and support for HIV prevention and drug abuse treatment efforts in Malaysia and possibly also in other Western Pacific countries. ..
  10. BRIEF BEHAVIORAL THERAPY TO ENHANCE TREATMENT ENGAGEMENT
    Richard Schottenfeld; Fiscal Year: 2000
    ..In Phase 4, we plan to develop gender and ethnicity specific videotapes and to pilot BEST in group therapy. ..
  11. BRIEF BEHAVIORAL THERAPY TO ENHANCE TREATMENT ENGAGEMENT
    Richard Schottenfeld; Fiscal Year: 1999
    ..In Phase 4, we plan to develop gender and ethnicity specific videotapes and to pilot BEST in group therapy. ..
  12. COUNSELING CONDITONS FOR THRICE WEEKLY BUPRENORPHINE
    Richard Schottenfeld; Fiscal Year: 1999
    ..Utilization and costs of services, spillover effects in the PCC, and patient and staff perceptions of benefits and problems with PCC agonist maintenance treatment will also be evaluated. ..
  13. Pain and Opioid Dependence (POD)
    Richard S Schottenfeld; Fiscal Year: 2010
    ....
  14. Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
    Richard Schottenfeld; Fiscal Year: 2009
    ..Data analyses will focus on the intention-to treat sample. The study results will inform practice guidelines and policies regarding buprenorphine treatment. ..
  15. Pain and Opioid Dependence (POD)
    Richard Schottenfeld; Fiscal Year: 2009
    ....
  16. Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
    Richard Schottenfeld; Fiscal Year: 2009
    ..Data analyses will focus on the intention-to treat sample. The study results will inform practice guidelines and policies regarding buprenorphine treatment. ..
  17. DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT
    Richard Schottenfeld; Fiscal Year: 2000
    ..The effects of baseline predictors and their interactions with treatment condition on these outcomes will also be evaluated. ..
  18. HIV Risk Reduction and Drug Abuse Treatment in Malaysia
    Richard Schottenfeld; Fiscal Year: 2004
    ..The results of the study will inform government policy and support for HIV prevention and drug abuse treatment efforts in Malaysia and possibly also in other Western Pacific countries. ..
  19. DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT
    Richard Schottenfeld; Fiscal Year: 2003
    ..The effects of baseline predictors and their interactions with treatment condition on these outcomes will also be evaluated. ..
  20. COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE
    Richard Schottenfeld; Fiscal Year: 1999
    ..abstract_text> ..
  21. DISULFIRAM FOR COCAINE ABUSE IN BUPRENORPHINE TREATMENT
    Richard Schottenfeld; Fiscal Year: 2001
    ..The effects of baseline predictors and their interactions with treatment condition on these outcomes will also be evaluated. ..
  22. COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE
    Richard Schottenfeld; Fiscal Year: 2001
    ..abstract_text> ..
  23. COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
    Richard Schottenfeld; Fiscal Year: 2001
    ..Utilization and costs of services, spillover effects in the PCC, and patient and staff perceptions of benefits and problems with PCC agonist maintenance treatment will also be evaluated. ..
  24. HIV Risk Reduction and Drug Abuse Treatment in Malaysia
    Richard Schottenfeld; Fiscal Year: 2001
    ..The results of the study will inform government policy and support for HIV prevention and drug abuse treatment efforts in Malaysia and possibly also in other Western Pacific countries. ..
  25. COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
    Richard Schottenfeld; Fiscal Year: 2002
    ..Utilization and costs of services, spillover effects in the PCC, and patient and staff perceptions of benefits and problems with PCC agonist maintenance treatment will also be evaluated. ..
  26. COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
    Richard Schottenfeld; Fiscal Year: 2003
    ..Utilization and costs of services, spillover effects in the PCC, and patient and staff perceptions of benefits and problems with PCC agonist maintenance treatment will also be evaluated. ..
  27. Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
    Richard S Schottenfeld; Fiscal Year: 2010
    ..Data analyses will focus on the intention-to treat sample. The study results will inform practice guidelines and policies regarding buprenorphine treatment. ..